Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
One of the first long-term studies on the effects of highly active antiretroviral therapy shows that only about 39% of people who began therapy between 1996 and 1997 and stuck to it for four years were able to achieve a CD4-cell count above 500. The study, published in the October 13 edition of Archives of Internal Medicine, also shows that 15.6% of the 2,235 participants never posted a CD4 count above 200, an AIDS-defining threshold. Those who did achieve CD4 counts above 500 after four years were more likely to have had higher nadir and baseline CD4 levels and a more sustained reduction in viral loads than those who did not reach the 500-cell mark.
From our Sponsors
Most Popular
Plus: Featured Video